Minimal information is available regarding changes in whole-body metabolism in ovarian cancer patients, and no study has assessed whole-body lipid metabolism in this patient population. In this pilot study we will assess fasting and postprandial lipid metabolism of ovarian cancer patients before, during, and after treatment via indirect calorimetry.
Women
Age >18
Presumed ovarian cancer diagnosis (i.e. those being clinically evaluated for suspicion of ovary cancer)
Planned treatment course for ovarian cancer involving cytoreductive surgery followed by chemotherapy
Pregnancy
Inability to provide voluntary informed consent
Inability to consume the pre-study visit meal/snack and/or the study visit meal due to strict dietary restrictions
Illicit substance use (e.g. cocaine, methamphetamines, heroin, street drugs) - marijuana and CBD oil and related supplements will be considered on a case-by-case basis by the principal investigators